Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata Nifty MidSmall Healthcare Index Fund | Axis BSE Sensex Index Fund | |
|---|---|---|
| Category | Index Funds (Equity) | Index Funds (Equity) |
| Plan | Regular | Regular |
| Fund house | Tata | Axis |
| AUM | ₹210 Cr | ₹54 Cr |
| NAV | ₹15.6794 | ₹11.6440 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | — | 2.7 years |
| Expense ratio | 1.1% | 0.8% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.
Returns
| Tata Nifty MidSmall Healthcare Index Fund | Axis BSE Sensex Index Fund | |
|---|---|---|
| 1 month | — | +13.62% |
| 3 months | — | +8.13% |
| 6 months | — | +11.87% |
| YTD | — | −1.08% |
| 1 year | — | −1.64% |
| 3 years (CAGR) | — | — |
| 5 years (CAGR) | — | — |
| 10 years (CAGR) | — | — |
| Since launch | — | +6.03% |
Risk
| Tata Nifty MidSmall Healthcare Index Fund | Axis BSE Sensex Index Fund | |
|---|---|---|
| Volatility | — | — |
| Downside volatility | — | — |
| Sharpe | — | — |
| Sortino | — | — |
| Calmar | — | — |
| Return / risk | — | — |
| Deepest fall | — | −16.15% |
| Days to recover | — | — |
| Below its high | — | −1.73% |
Against benchmark
| Tata Nifty MidSmall Healthcare Index Fund | Axis BSE Sensex Index Fund | |
|---|---|---|
| Alpha | — | — |
| Beta | — | — |
| R² | — | — |
| Up capture | — | — |
| Down capture | — | — |
| Tracking error | — | — |
| Information ratio | — | — |
| Treynor | — | — |
Consistency
| Tata Nifty MidSmall Healthcare Index Fund | Axis BSE Sensex Index Fund | |
|---|---|---|
| Best 1-year | — | +13.68% |
| Middle 1-year | — | +1.44% |
| Worst 1-year | — | −13.10% |
| 1-year periods with a loss | — | 44.1% |
| Middle 3-year | — | — |
| Positive months | — | — |
| Best day | — | +3.94% |
| Worst day | — | −5.66% |
| Worst 5% day | — | −1.28% |
| Positive days | — | 49.7% |
| NAVs a year | — | 251 |
SIP of ₹10,000 a month
| Tata Nifty MidSmall Healthcare Index Fund | Axis BSE Sensex Index Fund | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | — | — |
| 1-year XIRR | — | +12.16% |
Holdings overlap i
| Tata Nifty MidSmall Healthcare Index Fund | Axis BSE Sensex Index Fund | |
|---|---|---|
| Tata Nifty MidSmall Healthcare Index Fund Regular · filing Oct 2026 | — | 0% |
| Axis BSE Sensex Index Fund Regular · filing Oct 2026 | 0% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Tata Nifty MidSmall Healthcare Index Fund and Axis BSE Sensex Index Fund
Overlap
0.0%
smaller weight of each shared stock, added up
Stocks in common
0
of 30 and 30
Weight in common
0% · 0%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
These two funds hold no stock in common in these filings, so their overlap is 0%.
Only in Tata Nifty MidSmall Healthcare Index Fund (30)
| Laurus Labs Limited | 14.12% |
| Lupin Limited | 7.36% |
| Aurobindo Pharma Limited | 7.00% |
| Fortis Healthcare Limited | 6.03% |
| Glenmark Pharmaceuticals Limited | 5.22% |
| Alkem Laboratories Limited | 4.65% |
| Mankind Pharma Limited | 4.26% |
| IPCA Laboratories Limited | 4.04% |
| Gland Pharma Limited | 3.72% |
| Biocon Limited | 3.70% |
| Sai Life Sciences Limited | 3.25% |
| Acutaas Chemicals Limited | 3.13% |
| Krishna Institute Of Medical Sciences Limited | 2.82% |
| Aster DM Quality Care Limited | 2.74% |
| Neuland Laboratories Limited | 2.56% |
| Ajanta Pharma Limited | 2.41% |
| Wockhardt Limited | 2.37% |
| Dr. Lal Path Labs Limited | 2.24% |
| Piramal Pharma Limited | 2.24% |
| Abbott India Limited | 2.01% |
| Granules India Limited | 1.87% |
| Onesource Specialty Pharma Limited | 1.85% |
| Narayana Hrudayalaya Limited | 1.79% |
| Global Health Limited | 1.70% |
| Glaxosmithkline Pharmaceuticals Limited | 1.56% |
and 5 smaller holdings (5.6% of the fund).
Only in Axis BSE Sensex Index Fund (30)
| HDFC Bank Limited | 11.98% |
| ICICI Bank Limited | 11.34% |
| Reliance Industries Limited | 8.75% |
| Bharti Airtel Limited | 6.97% |
| Larsen & Toubro Limited | 5.12% |
| Infosys Limited | 4.73% |
| State Bank of India | 4.53% |
| Axis Bank Limited | 3.94% |
| Kotak Mahindra Bank Limited | 3.85% |
| ITC Limited | 2.91% |
| Mahindra & Mahindra Limited | 2.89% |
| Tata Consultancy Services Limited | 2.87% |
| Bajaj Finance Limited | 2.85% |
| Eternal Limited | 2.82% |
| Sun Pharmaceutical Industries Limited | 2.18% |
| Titan Company Limited | 2.06% |
| Hindustan Unilever Limited | 1.89% |
| HCL Technologies Limited | 1.71% |
| NTPC Limited | 1.70% |
| Maruti Suzuki India Limited | 1.67% |
| Adani Ports and Special Economic Zone Limited | 1.64% |
| Tata Steel Limited | 1.57% |
| Bharat Electronics Limited | 1.50% |
| UltraTech Cement Limited | 1.48% |
| Power Grid Corporation of India Limited | 1.37% |
and 5 smaller holdings (5.9% of the fund).
Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.
Sectors and company size
| Tata Nifty MidSmall Healthcare Index Fund | Axis BSE Sensex Index Fund | |
|---|---|---|
| Large companies | — | 100.2% |
| Mid companies | 68.2% | — |
| Small companies | 32.0% | — |
| Top 10 holdings | 60.1% | 64.1% |
| Largest sector | Pharmaceuticals & Biotechnology 81% | Banks 36% |